Product Name | MF | CAS | Details |
---|
CEF32, Epstein-Barr Virus latent NA-3C (281-290) | C59H88N14O18 | Details |
HBV Core (107-115) | Details |
Lauryl-LF 11 | C81H134N26O15 | 832729-14-3 | Details |
CEF21, Cytomegalovirus, CMV pp65 (417-426) | C38H67N13O13S | Details |
Flagelin 22 | C93H162N32O34 | 304642-91-9 | Details |
Influenza HA (126-138) | C52H81N19O22 | 207349-63-1 | Details |
Competence-Stimulating Peptide-2 | C101H172N28O23S | 1174553-84-4 | Details |
Pyrrhocoricin | C113H179N33O34 | 156548-23-1 | Details |
CEF8, influenza virus NP 383-391 | Details |
NS2(114-121), Influenza | Details |
RIP (free acid) | C45H55N9O12 | 228544-21-6 | Details |
SEB Domain (144-153) | C50H90N14O17 | 210229-94-0 | Details |
KK4A | C74H138N22O19 | Details |
Indolicidin | C100H132N26O13 | 140896-21-5 | Details |
CEF17, Epstein-Barr Virus latent NA-3A (158-166) | C52H86N16O13 | Details |
Lactoferricin | C141H224N46O29S3 | 146897-68-9 | Details |
Innate Defense Regulator-1 | Details |
PA (224-233), Influenza | C53H80N14O17 | 271573-27-4 | Details |
CD36 Peptide P(93-110) | C96H151N29O33S | Details |
HCV, NS4A-Like Peptide | Details |
LL-37 KRI | C109H190N36O29 | 672333-78-7 | Details |
CEF12, Epstein-Barr Virus latent NA3B (399-408), AVF | C49H81N15O16 | Details |
CEF14, EBV Rta Protein (28-37) | C55H81N13O18S | 216862-58-7 | Details |
LL-37 SKE | C119H204N36O30 | 1072128-56-3 | Details |
LCMV-NP205 | Details |
CEF18, Epstein-Barr Virus latent NA-3C (258-266) | C54H91N15O15 | Details |
CEF26, Influenza Virus NP (265-274) | C43H77N15O11 | Details |
CEF6 | C48H78N10O14S | 913545-15-0 | Details |
CEF10, Epstein-Barr Virus LMP2 (426-434) | C39H71N9O11S2 | Details |
Influenza HA (110-120) | C68H97N15O19 | Details |
LL-37 GKE | C119H202N38O28 | 913736-92-2 | Details |
HPV E7 protein (49-57) | Details |
CSP1 | Details |
Influenza HA (307-319) | C69H118N18O19 | 528526-85-4 | Details |
CEF7, Influenza Virus NP (380-388) | C55H84N16O14 | 147100-46-7 | Details |
Influenza HA (204-212) | C49H73N11O15 | Details |
Influenza Virus A/Aichi/2/68 Haemagglutinin HA1 (195-209), X-31 | Details |
Influenza HA (91-108) | Details |
CEF19, Epstein-Barr Virus latent NA-3A (458-466) | C49H70N14O14S | 157876-41-0 | Details |
LCMV gp33-41 | C48H73N11O13S | 151705-84-9 | Details |
Influenza A NP (366-374) Strain A/NT/60/68 | C36H59N11O17S2 | Details |
IV9 (476-484), HIV-1 RT Epitope | C46H78N12O12 | Details |
Apidaecin IB | C95H150N32O23 | 123276-94-8 | Details |
Prepro VIP (111-122) | C53H87N13O21 | Details |
Influenza A NP(366-374) Strain A/PR/8/35 | C38H63N11O18S2 | 132326-73-9 | Details |
Human Platelet Factor IV 18, C18G | Details |
LCMV GP (61-80) | Details |
Human CMV pp65 (495-503) | C42H74N10O12S | 153045-21-7 | Details |
Biotinyl-KR-12 (human) | C81H140N26O18S | 2022956-47-2 | Details |
CMV pp65 peptide | Details |
Lysozyme C (46-61) (chicken) | C72H116N22O29 | 62982-31-4 | Details |
HSV-gB2 (498-505) | C41H67N11O13 | 149997-91-1 | Details |
CEF11, Epstein-Barr Virus BMLF1 (280-288) | C40H73N9O11S2 | Details |
CEF27, Epstein-Barr Virus BRLF-1 lytic (148-156) | C51H82N16O14 | 254110-79-7 | Details |
Influenza HA (110-119) | C63H90N14O16 | 132031-50-6 | Details |
Glycoprotein (276-286) | C46H70N12O17S | 160543-97-5 | Details |
Bactenecin 2A | Details |
CEF2, Influenza Virus PA (46-54) | C60H75N11O14S | Details |
LL-37 LLG | C119H196N32O29 | 740800-39-9 | Details |
CHRG01 | 646038-39-3 | Details |
HIV p17 Gag (77-85) | C44H72N10O15 | 147468-65-3 | Details |
CEF9, Influenza Virus M1 128-135 | C37H60N8O11S2 | Details |
OV-1, sheep | C105H188N34O21 | 326855-45-2 | Details |
MMK-1 | C75H123N19O18S | 271246-66-3 | Details |
CEF1, Influenza Matrix Protein M1 (58-66) | C49H75N9O11 | 141368-69-6 | Details |
CEF29, Epstein-Barr Virus latent NA-3B (416-424) | C48H80N10O14 | Details |
GP(33-41) | C46H69N11O13S | 161928-86-5 | Details |
Mycobacterium tuberculosis Protein Ag85A | Details |
CEF24, Influenza Virus PB1 Peptide (591-599) | C40H60N10O15 | Details |
Histatin-8 [Hemagglutination-Inhibiting Peptide (HIP) | C70H99N25O17 | 127637-03-0 | Details |
Drosocin | C98H160N34O24 | 149924-99-2 | Details |
Ac-MDKVLNRE | Details |
CEF23, Cytomegalovirus, CMV pp65 (123-131) | C50H74N14O13 | Details |
Influenza HA (518-526) | C42H69N9O15 | 186302-15-8 | Details |
CFP10 (71-85) | C72H120N24O25 | 646997-09-3 | Details |
Chemerin-9 (149-157) | C54H66N10O13 | 676367-27-4 | Details |
CEF4 | C53H93N15O13 | 199727-68-9 | Details |
CD36 Peptide P(139-155) | C87H133N25O26S | Details |
LL-37 (18-29) | Details |
Influenza Matrix Protein (61-72) | C63H97N15O18 | 1286245-45-1 | Details |
AMPs WR | Details |
CEF30, Epstein-Barr Virus BRLF1 (134-142) | C42H70N10O13S | Details |
Aurein 1.1 | Details |
Prepro VIP (156-170) | C71H106N16O31 | 107902-86-3 | Details |
NS4A-NS4B Hepatitis Virus C | C29H44N6O16S2 | Details |
LLO (91-99) | Details |
B8R (20-27) | Details |
Influenza Virus Nucleoprotein (311-325) | Details |
LF11 TFA | Details |
CEF16, Epstein-Barr Virus latent NA-3A (337-347) | C49H77N15O11 | Details |
CEF22, Cytomegalovirus, CMV pp65 (378-389) | C58H90N12O24 | Details |
CEF33, Cytomegalovirus, HCMV pp65 | C64H78N12O19 | Details |
CEF28, Epstein-Barr Virus latent NA-3A (603-611) | C45H83N17O13 | Details |
CEF25, Influenza Virus NP (44-52) | C46H74N10O17S | Details |
CEF3 | C42H74N10O12 | 199727-62-3 | Details |
HSV-1-amide UL 26 Open Reading Frame (242-255) | C80H117N21O20S | 396716-24-8 | Details |
LL(17-29) | Details |
CEF5, Influenza Virus NP (91-99) | C46H78N14O12 | Details |
CEF15, Epstein-Barr Virus Lytic Cycle Protein BZLF-1(190-197) | C47H82N14O10 | Details |
CEF31, Epstein-Barr Virus latent NA-3A (379-387) | C55H94N18O10 | Details |
Product Total: Product Page: | ||||
196 197 198 199 200 201 202 203 204 205 206 207 208 209 210 211 212 213 214 215 216 217 218 219 220 221 222 223 224 225 226 227 228 229 230 231 232 233 234 235 236 237 238 239 240 241 242 243 244 245 246 247 248 249 250 251 252 253 254 255 256 257 258 259 260 261 262 263 264 265 266 267 268 269 270 271 272 273 274 275 276 277 278 279 280 281 282 283 284 285 286 287 288 289 290 291 292 293 294 295 296 297 298 |